Should intravenous thrombolysis keep a place in the treatment of acute ST-elevation myocardial infarction?

European Heart Journal

Volumn 27, Issue 10, 2006, Pages 1131-1133

  Danchin, Nicolas ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; AMBULANCE; BLOOD CLOT LYSIS; CLINICAL TRIAL; EDITORIAL; HEART INFARCTION; HEART MUSCLE REPERFUSION; HUMAN; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; ST ELEVATION MYOCARDIAL INFARCTION; SURVIVAL; SYMPTOMATOLOGY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

HUMANS; MYOCARDIAL INFARCTION; THROMBOLYTIC THERAPY;

EID: 33646740760     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi740     Document Type: Editorial

References (11)

1. COMMIT Collaborative Group. Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005;366:1607-1621.
2. Björklund E, Stenestrand U, Lindbäck J, Svensson L, Wallentin L, Lindahl B, on behalf of the RIKS-HIA Investigators. Pre-hospital thrombolysis delivered by paramedics is associated with reduced time delay and mortality in ambulance-transported real-life patients with ST-elevation myocardial infarction. Eur Heart J 2006;27:1146-1152. First published on April 19, 2006, doi:10.1093/eurheartj/ehi886.
3. The European Myocardial Infarction Project Group. Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. N Engl J Med 1993;329:383-389.
4. Morrison LJ, Verbeek PR, McDonald AC, Sawadsky BV, Cook DJ. Mortality and prehospital thrombolysis for acute myocardial infarction. A meta-analysis. JAMA 2000;283:2686-2692.
5. Simon T, Mary-Krause M, Cambou JP, Hanania G, Guéret P, Lablanche JM, Blanchard D, Genès N, Danchin N, on behalf of the USIC Investigators. Impact of age and gender on in-hospital and late mortality after acute myocardial infarction: increased early risk in younger women. Results from the French nation-wide USIC registries. Eur Heart J, in press.
6. Bonnefoy E, Lapostolle F, Leizorovicz A, Steg G, Mc Fadden EP, Dubien PY, Cattan S, Boullenger E, Machecourt J, Lacroute JM, Cassagnes J, Dissait F, Touboul P, on behalf of the CAPTIM study group. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet 2002;360:825-829.
7. Danchin N, Blanchard D, Steg PG, Sauval P, Hanania G, Goldstein P, Cambou JP, Guéret P, Vaur L, Boutalbi Y, Genès N, Lablanche JM, for the USIC 2000 investigators. Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome. Results from the French nationwide USIC 2000 registry. Circulation 2004;110:1909-1915.
8. Steg PG, Bonnefoy E, Chabaud S, Lapostolle F, Dubien PY, Cristofini P, Leizorovicz A, Touboul P, for the CAPTIM investigators. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty. Data from the CAPTIM randomized clinical trial. Circulation 2003;108:2851-2856.
9. Keeley C, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13-20.
10. PCAT collaborators. Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow-up and analysis of individual patient data from randomized trials. Am Heart J 2003;145:47-57.
11. Bassand JP, Danchin N, Filippatos G, Gitt A, Hamm C, Silber S, Tubaro M, Weidinger F. Implementation of reperfusion therapy in acute myocardial infarction. A policy statement from the European Society of Cardiology. Eur Heart J 2005;26:2733-2741.